Aligned with its commitment to drive high-quality practices that impro...
"Today, regenerative medicine, stem cells, neurology have tremendous p...
New Page 1 RFCL leads change innovatively ...
A robust healthcare system drives GDP growth, productivity and employm...
RANK 9 Revenue 123 Crore Si...
After hitting headlines for its $3.2 billion acquisition of Ranbaxy fo...
Chairman Emeritus of Tata Sons Limited, Ratan N Tata has invested in D...
Piramal Enterprises' Consumer Products Division announces the acquisit...
The global treatment market for peripheral artery disease (PAD) will e...
Pfizer has announced that investigational antibody-drug conjugate (ADC...
The biosimilars portfolio saw a robust growth in H1FY14, driven by the...
The Type 1 Diabetes Mellitus (T1DM) market across the eight major coun...
Teva Pharmaceutical Industries and Heptares Therapeutics announce that...
The 8th Edition of annual Bio Quiz conducted along with Bangalore INDI...
"With plans to launch this product early next year through our partner...
Ranibizumab is a therapeutic antibody fragment designed specifically f...
Siemens Financial Services (SFS) recently released a new research repo...
India's pharmaceutical industry is expected to expand at a CAGR of 14....
